Docosapentaenoic acid (DPA) designates any straight chain 22:5 fatty acid, that is a straight chain open chain type of polyunsaturated fatty acid (PUFA) which contains 22 carbons and 5 double bonds. DPA is primarily used to designate two isomers, all-cis-4,7,10,13,16-docosapentaenoic acid (i.e. 4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid) and all-cis-7,10,13,16,19-docosapentaenoic acid (i.e. 7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid). They are also commonly termed n-6 DPA and n-3 DPA, respectively; these designations describes the position of the double bond being 6 or 3 carbons closest to the (omega) carbon at the methyl end of the molecule and is based on the biologically important difference that n-6 and n-3 PUFA are separate PUFA classes, i.e. the omega-6 fatty acids and omega-3 fatty acids, respectively. Mammals, including humans, can not interconvert these two classes and therefore must obtain dietary essential PUFA fatty acids from both classes in order to maintain normal health (see essential fatty acids).
- See essential fatty acid#nomenclature for nomenclature.
all-cis-4,7,10,13,16-docosapentaenoic acid (osbond acid)
n-6 DPA is an ω-6 fatty acid with the trivial name osbond acid. It is formed by the stepwise elongation and desaturation of arachidonic acid i.e. 5Z,8Z,11Z,14Z-eicosatetraenoic acid (5,8,11,14-20:4n-6) to the 24 carbon PUFA intermediate (i.e. 6,9,12,15,18:24-5n-6) and the retro-conversion of this intermediate to DPAn-6 as follows:
all-cis-7,10,13,16,19-docosapentaenoic acid (clupanodonic acid)
n-3 DPA is an n-3 fatty acid with the trivial name clupanodonic acid. It is an intermediary between eicosapentaenoic acid (EPA, 5,8,11,14,17-20:5n-3) and docosahexaenoic acid (DHA, 22:6 ω-3) in the following stepwise pathway in which DPAn-3 is a precursor to DHA (6,9,12,15,18,21:24:6n-3) and the final product, 4,7,10,13,16,19-22:6n-3, can be retro-converted to DPAn-3:
Mammalian cells, including human cells, metabolize DPAn-3 to an array of products that are members of the specialized proresolving mediators class of PUFA metabolites. These metabolites include seven resolvins Ds (RvT1, RvT2, RvT3, RvT4, RvD1n-3, RvD2n-3, and RvD5n-3; see specialized proresolving mediators#n-3 DPA-derived resolvins and Resolvin); two protectins (PD1n-3 and PD2n-3; see specialized proresolving mediators#n-3 DPA-derived protectins/neuroprotectins and neuroprotectin); and three maresins (MaR1n-3, MaR2n-3,and MaR3n-3l see specialized proresolving mediators#n-3 DPA-derived maresins and maresin.
- Fish oil, menhaden .668 22:5 n-3 (DPA) (g) Per Measure
- Fish oil, salmon .407 22:5 n-3 (DPA) (g) Per Measure
- Salmon, red (sockeye), filets with skin, smoked (Alaska Native) 0.335 22:5 n-3 (DPA) (g) Per Measure
- Fish, salmon, Atlantic, farmed, raw .334 22:5 n-3 (DPA) (g) Per Measure
- Beef, variety meats and by-products, brain, cooked, simmered 22:5 n-3 (DPA) (g) Per Measure
Seal meat and human breast milk are rich in DPA.
Clupanodonic acid, an omega-3 fatty acid, along with its metabolite DHA and other long chain omega-3 fatty acids, is under study to determine properties of omega-3 fats in humans, such as in inflammation mechanisms.
- Edwards IJ, O'Flaherty JT (2008). "Omega-3 Fatty Acids and PPARgamma in Cancer". PPAR Research 2008: 358052. doi:10.1155/2008/358052. PMC 2526161. PMID 18769551.
- Spector AA, Kim HY (2015). "Discovery of essential fatty acids". Journal of Lipid Research 56 (1): 11–21. doi:10.1194/jlr.R055095. PMC 4274059. PMID 25339684.
- Sprecher H (2000). "Metabolism of highly unsaturated n-3 and n-6 fatty acids". Biochimica Et Biophysica Acta 1486 (2-3): 219–31. PMID 10903473.
- Spector AA (1999). "ssentiality of fatty acids". Lipids. 34 Suppl: S1–3. PMID 10419080.
- Yazdi, PG (Nov 2013). "A review of the biologic and pharmacologic role of docosapentaenoic acid n-3". F1000Res. 2: 256. doi:10.12688/f1000research.2-256.v2. PMC 4162505. PMID 25232466.
- "DPA Nutrient List." National Nutrient Database for Standard Reference Release 27.
- Dalli, J; Chiang, N; Serhan, C. N. (2015). "Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections". Nature Medicine 21 (9): 1071–5. doi:10.1038/nm.3911. PMC 4560998. PMID 26236990.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.